Merck Digital Sciences Studio Opens in Canada to Accelerate Biopharmaceutical Innovation
Congrats to Simmunome Inc. and Nanofacile for being selected to join the first-ever Canadian cohort of the Merck Digital Sciences Studio (MDSS)—a major global accelerator for AI-driven health innovation.

1 janvier 1970



.jpeg)
